SCHEMBL17248232

SCHEMBL17248232

c1ccc(-c2cccc(-n3c4ccccc4c4cc5c(cc43)c3ccccc3n5-c3cccc(-n4c5ccccc5c5ccccc54)c3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.45
KDM4E B2RXH2 2/20 0.45
ATM Q13315 1/20 0.45
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
RAB9A P51151 1/20 0.40
COMT P21964 1/20 0.36
GAA P10253 1/20 0.35
ASIC3 Q9UHC3 1/20 0.35
IL1R1 P14778 1/20 0.33
MAPT P10636 2/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
PDE10A Q9Y233 1/20 0.32
CNR1 P21554 1/20 0.32
ACHE P22303 1/20 0.32
HSD17B10 Q99714 2/20 0.32
KDR P35968 1/20 0.32
PARP1 P09874 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18833213 0.96 L3MBTL1 (0.44) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL10060900 0.96 L3MBTL1 (0.50) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL17248227 0.95 ATM (0.42) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL10060917 0.93 L3MBTL1 (0.47) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL12036321 0.93 L3MBTL1 (0.47) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL10061162 0.93 L3MBTL1 (0.42) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL10027563 0.93 MEN1 (0.46) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL12456729 0.93 L3MBTL1 (0.42) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL10027567 0.92 L3MBTL1 (0.41) L3MBTL1KDM4EATMKMT2AMEN1
SCHEMBL10027583 0.92 L3MBTL1 (0.49) L3MBTL1KDM4EATMKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10361378-B2 Organic electroluminescent device NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-23 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361378-B2 Organic electroluminescent device ELF3, DDT, LEF1 L3MBTL1 74/4885KDM4E 1228/4885ATM 3768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.